Cibc Private Wealth Group, LLC Bridge Bio Pharma, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,800 shares of BBIO stock, worth $40,230. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,800
Previous 800
125.0%
Holding current value
$40,230
Previous $20,000
125.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
291Shares Held
171MCall Options Held
10.4MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$565 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$561 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$317 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$278 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$136 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.31B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...